Please provide your email address to receive an email when new articles are posted on . CHICAGO — Results presented here showed a significantly greater overall clinical success rate with cervical disc ...
BioRestorative Therapies, Inc. announced that the FDA has cleared its Investigational New Drug application for BRTX-100, marking it as the first stem cell product candidate approved for evaluation in ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Early composite clinical success showed similar outcomes ...
This article was written for our sponsor, Dr. Sameer Mathur, Orthopedic Surgeon. Approximately 1.1 million patients in the United States suffer from symptomatic cervical disc disease each year. This ...